• Provide strong technical support and activity management to CROs and R&D colleagues • Evaluate assay development (AD) and sample testing vendors for suitability to conduct clinical phase-appropriate AD and testing activities. • Develop and implement assays for clinical and nonclinical vaccine study applications, including human Phase 2 and Phase 3 trials and NHP studies. • Implement assays that measure antigen-specific cellular and humoral immune responses and deploy these to better understand the mechanism of action of Sabin’s vaccines. • Design analytical assay qualification and validation protocols and work closely with vendors to guarantee their accurate execution. • Manage related assay tech transfers and review validation reports. • Author technical responses to assays-specific questions and directives from regulatory authorities and stakeholders. • In collaboration with clinical and statistical SMEs, review, draft, and revise assay related sections of data transfer agreements, statistical analysis protocols (SAPs), SOPs, and study reports. • Collaborate with assays vendors and clinical CROs to ensure the seamless transfer of immunological samples (blood, cells, serum/plasma) between clinical sites and vendors located on different continents. • Work with clinical testing vendors to ensure GLP-compliant assay execution and documentation. • Maintain internal operational documents under GxPs, adhering to best practices concordant with Phase 3 and commercial level of vaccine regulatory compliance. • Work with clinical team members to ensure GCP-compliant data analyses, adherence to blinding protocols, and stewardship over clinical immunology samples (e.g., serum and PBMCs) and assay data. • Collaboratively support the design/ and implementation an immune correlate of protection testing strategy for NHPs that supports the animal rule-based approach to vaccine licensure • Devise, maintain and guide the implementation of best practices such establishing/certifying the appropriate compliancy level for a matrix of assays used in NHP studies • Participate in the drafting and review of study reports, SOPs, SAPs, and publications of NHP study outcomes • Work closely with the Translational R&D leadership to provide assay-related expertise for NHP and other animal studies to efficiently develop and characterize mechanistic immunological assays needed for animal rule-based licensure strategies: • Provide assay support for the design and execution of experiments that lay groundwork for NHP to human immunobridging • Further characterize immune correlates of protection • Assess the relevance and rigor of current experimental approaches and assay methods; improve immunogenicity evaluation strategies • Facilitate cross-functional planning of assays activities to align on schedules, dependencies, and funding to support phase 2 and 3 trial completion and licensure. • Work with project management to operationalize experimental and assays goals and associated timelines, budgets, and risk mitigation strategies. • Facilitate data collection, quality control, organization, and analysis to strengthen the data infrastructure of the Translational R&D team • Participate in meetings with consultants, partners and funders, including biweekly meetings with the Biomedical Advanced Research and Development Authority (BARDA); prepare and present assays-related meeting materials • Serve as a subject matter expert for immune assays for communications with funders and global health stakeholders (e.g., WHO, Gavi, Coalition for Epidemic Preparedness Innovations (CEPI), and related) • Participate in the preparation of grant applications, contracts and other fundraising efforts